FXH · ARCA · ETF
First Trust Health Care AlphaDEX (FXH) Price, Holdings & Fees
First Trust Health Care AlphaDEX (FXH) closed at $596.30 on Oct 9, 2026, down 0.60% from the previous close of $599.91.
Share price, past year
1Y +26.61%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $596.30 |
| Sep 30, 2026 | $570.51 |
| Aug 31, 2026 | $603.49 |
| Jul 31, 2026 | $555.82 |
| Jun 30, 2026 | $548.99 |
| May 29, 2026 | $585.33 |
| Apr 30, 2026 | $595.20 |
| Mar 31, 2026 | $581.69 |
| Feb 27, 2026 | $541.08 |
| Jan 30, 2026 | $527.89 |
| Dec 31, 2025 | $507.51 |
| Nov 28, 2025 | $476.79 |
| Oct 31, 2025 | $480.24 |
Key statistics
- Expense ratio
- 0.61%
- as of Jul 31, 2025
- Net assets
- $1B
- as of Jul 31, 2026
- Holdings
- 75
- as of Jul 31, 2026
- 52-week range
- $467.26 – $610.44
First Trust Health Care AlphaDEX's expense ratio is 0.61%: $61.00 a year on $10,000 invested.
Holdings
First Trust Health Care AlphaDEX held 75 investments worth $1.05B as of Jul 31, 2026. Its largest holding was REGENERON PHARMACEUTICALS INC, at 2.77% of the fund.
| # | Holding | % of fund | Value |
|---|---|---|---|
| 1 | REGENERON PHARMACEUTICALS INCREGN | 2.77% | $29.03M |
| 2 | UNIVERSAL HEALTH SERVICES INCUHS | 2.57% | $26.88M |
| 3 | SOLVENTUM CORPSOLV | 2.51% | $26.28M |
| 4 | BOSTON SCIENTIFIC CORPBSX | 2.48% | $25.98M |
| 5 | ZIMMER BIOMET HOLDINGS INCZBH | 2.47% | $25.89M |
| 6 | GUARDANT HEALTH INCGH | 2.45% | $25.62M |
| 7 | DAVITA INCDVA | 2.44% | $25.61M |
| 8 | PFIZER INCPFE | 2.35% | $24.65M |
| 9 | TENET HEALTHCARE CORPTHC | 2.30% | $24.13M |
| 10 | CIGNA GROUP (THE)CI | 2.29% | $24.02M |
| 11 | GLOBUS MEDICAL INCGMED | 2.26% | $23.66M |
| 12 | MEDLINE INCMDLN | 2.26% | $23.63M |
| 13 | NATERA INCNTRA | 2.23% | $23.41M |
| 14 | CORCEPT THERAPEUTICS INCCORT | 2.23% | $23.33M |
| 15 | CENTENE CORPCNC | 2.20% | $23.00M |
| 16 | AXSOME THERAPEUTICS INCAXSM | 2.02% | $21.14M |
| 17 | ENCOMPASS HEALTH CORPEHC | 1.86% | $19.47M |
| 18 | MEDTRONIC PLCMDT | 1.85% | $19.34M |
| 19 | RESMED INCRMD | 1.83% | $19.18M |
| 20 | ZOETIS INCZTS | 1.82% | $19.06M |
| 21 | QIAGEN NVQGEN | 1.79% | $18.76M |
| 22 | HALOZYME THERAPEUTICS INCHALO | 1.78% | $18.69M |
| 23 | INCYTE CORPINCY | 1.78% | $18.68M |
| 24 | ARROWHEAD PHARMACEUTICALS INCARWR | 1.76% | $18.40M |
| 25 | NEUROCRINE BIOSCIENCES INCNBIX | 1.67% | $17.54M |
Top 25 of 75 holdings, as of Jul 31, 2026. Percentages are of the fund's net assets.
What the fund owns
| Asset type | % of fund |
|---|---|
| Stocks | 99.82% |
| Cash and short-term investments | 0.17% |
| Repurchase agreements | 0.01% |
| Country | % of fund |
|---|---|
| United States | 93.34% |
| Ireland | 3.32% |
| Netherlands | 1.79% |
| Denmark | 1.55% |
Shares of net assets from the fund's N-PORT report. Funds that borrow can add up to more than 100%, with borrowing (such as repurchase agreements) shown as a negative share.
Monthly total returns
Over the 3 months to Jul 31, 2026, First Trust Health Care AlphaDEX's total return was +12.71%, as reported to the SEC.
| Month | Total return |
|---|---|
| Jul 31, 2026 | +3.96% |
| Jun 30, 2026 | +6.33% |
| May 31, 2026 | +1.96% |
The fund's own total returns as reported to the SEC (N-PORT), including reinvested distributions. Not the sample prices above.
Fund profile
- Name
- First Trust Health Care AlphaDEX
- Ticker
- FXH
- Exchange
- ARCA
- Fund type
- ETF
- Trust
- FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND
- SEC series ID
- S000017700
- SEC CIK
- 0001383496
- Fractional shares
- Yes
Recent SEC filings
- Sep 22, 2026
- Apr 10, 2026
- 485BPOSProspectus updateNov 28, 2025
- Oct 7, 2025
- Apr 8, 2025
- 485BPOSProspectus updateNov 27, 2024
- Oct 8, 2024
- Apr 8, 2024
Shareholder reports and prospectuses are filed by FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND, the trust behind First Trust Health Care AlphaDEX, and cover all of its funds.
Frequently asked questions
What is FXH's price?
First Trust Health Care AlphaDEX (FXH) closed at $596.30 on Oct 9, 2026, down 0.60% from the previous close of $599.91.
What is FXH's expense ratio?
First Trust Health Care AlphaDEX's expense ratio is 0.61%: $61.00 a year on $10,000 invested.
What does FXH hold?
First Trust Health Care AlphaDEX held 75 investments worth $1.05B as of Jul 31, 2026. Its largest holding was REGENERON PHARMACEUTICALS INC, at 2.77% of the fund. Its five largest holdings were REGENERON PHARMACEUTICALS INC, UNIVERSAL HEALTH SERVICES INC, SOLVENTUM CORP, BOSTON SCIENTIFIC CORP, ZIMMER BIOMET HOLDINGS INC.
How has FXH performed?
Over the 3 months to Jul 31, 2026, First Trust Health Care AlphaDEX's total return was +12.71%, as reported to the SEC.
Sources and methodology
Holdings, net assets and monthly returns come from the fund's N-PORT filing with the SEC, as of Jul 31, 2026 (filed Sep 22, 2026). The expense ratio is from the fund's prospectus or shareholder report, as of Jul 31, 2025. Prices are generated sample data for development. Data sources and disclosures